We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Medica 2025 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Immunology

Image: An immune response is initiated when an antigen-presenting cell (pink) presents foreign material to a T-cell (blue) (Photo courtesy of JAX)

Advanced Imaging Method Maps Immune Cell Connections to Predict Cancer Patients Survival

A new combination of imaging and computational techniques has been developed to study the connections between immune cells in breast cancer and melanoma. More...
06 Nov 2024
Image: The new method assesses which patients with metastatic triple-negative breast cancer could benefit from immunotherapy (Photo courtesy of Theinmozhi Arulraj and Aleksander Popel)

Computational Tool Predicts Immunotherapy Outcomes for Metastatic Breast Cancer Patients

Researchers have leveraged computational tools to create a method for assessing which patients with metastatic triple-negative breast cancer may benefit from immunotherapy. More...
31 Oct 2024
Image: Low NBR1 levels in hepatic stellate cells enhance interferon signaling in human hepatocellular carcinoma (Photo courtesy of Moscat and Diaz-Meco labs)

Biomarker Could Predict Immunotherapy Response in Liver Cancer

A preclinical study suggests it may soon be possible to identify which patients with hepatocellular carcinoma would respond favorably to immunotherapy. More...
25 Oct 2024
Image: Bone marrow affected by multiple myeloma, a disease against which PVR inhibition can increase the efficacy of immunotherapy (Photo courtesy of Cancer Epigenetics Group, IJC)

Epigenetic Test Could Determine Efficacy of New Immunotherapy Treatments Against Multiple Myeloma

Researchers have demonstrated an epigenetic test that predicts the effectiveness of new immunotherapy treatments for multiple myeloma, a blood cancer primarily affecting individuals over sixty. More...
11 Oct 2024
Image: The CELLSEARCH System is the first and only clinically validated, FDA-cleared system for identification, isolation, and enumeration of CTCs from a simple blood test (Photo courtesy of Menarini, Inc.)

Early Blood Test Predicts Survival in Patients with Metastatic Prostate Cancer

A new blood test, conducted when metastatic prostate cancer is first diagnosed, can predict which patients are most likely to respond to treatment and have the longest survival rates. More...
08 Oct 2024
Image: Anti-programmed cell death 1 (anti-PD-1) autoantibody as a biomarker for prognosis of cancer (Photo courtesy of Dr. Akinobu Takaki/Okayama University)

Blood Test Predicts Survival in Liver Cancer Patients

Researchers have discovered that serum autoantibody levels may serve as a predictive marker for treatment response in liver cancer patients. More...
20 Sep 2024
Image: The blood test measures lymphocytes  to guide the use of multiple myeloma immunotherapy (Photo courtesy of 123RF)

Simple Blood Test Identifies Multiple Myeloma Patients Likely to Benefit from CAR-T Immunotherapy

A simple blood test that counts lymphocytes (a type of white blood cell) to predict the success of CAR-T immunotherapy in patients with relapsed multiple myeloma will allow physicians to pursue alternative treatments more quickly. More...
25 Jul 2024
Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Gold Member
Ketosis and DKA Test
D-3-Hydroxybutyrate (Ranbut) Assay
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay


The Immunology channel of LabMedica deals with diagnostic techniques and immuonassays such as ELISA, pregnancy tests, immunoblotting, immunohistochemical staining, serology, and associated hardware.
GLOBE SCIENTIFIC, LLC